Holen Sie sich die Stockscreener-App
2.05
2.50%
0.05
Handel nachbörslich:
2.04
-0.010
-0.49%
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt SLS?
Forum
Prognose
Aktiensplit
Finanzdaten der Sellas Life Sciences Group Inc-Aktie (SLS)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Revenues |
-
|
- | - | - | - |
| Cost Of Revenue |
-
|
- | - | - | - |
| Selling, General, and Administrative |
5.04%
3.002
|
2.858 | 2.481 | 2.967 | 2.435 |
| Costs And Expenses |
13.36%
6.873
|
6.063 | 6.918 | 7.329 | 7.621 |
| Operating Income/Loss |
13.36%
-6.873
|
-6.063 | -6.918 | -7.329 | -7.621 |
| Nonoperating Income/Loss |
8.80%
0.272
|
0.25 | 0.181 | 0.221 | 0.151 |
| Income/Loss From Continuing Operations Before Tax |
13.36%
-6.873
|
-6.063 | -6.286 | -7.329 | -7.621 |
| Income/Loss From Continuing Operations After Tax |
13.56%
-6.601
|
-5.813 | -6.737 | -7.108 | -7.47 |
Net Income/Loss
|
13.56%
-6.601
|
-5.813 | -6.737 | -7.108 | -7.47 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Basic Average Shares |
12.30%
98.56
|
87.76 | 4.2618 | 68.25 | 57.63 |
| Diluted Average Shares |
12.30%
98.56
|
87.76 | 4.2618 | 68.25 | 57.63 |
| Basic Earnings Per Share |
0.00%
-0.07
|
-0.07 | -0.08 | -0.10 | -0.13 |
| Diluted Earnings Per Share |
0.00%
-0.07
|
-0.07 | -0.08 | -0.10 | -0.13 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
5.15%
1.45%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):